Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Pharmacoepidemiol Drug Saf ; 21(3): 276-80, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22231899

RESUMO

PURPOSE: The aim of this study was to determine whether the presence of symptoms would aid in the detection of valvular heart disease (VHD) in those exposed to pergolide. METHODS: Utilizing a prospective, cross-sectional study design, patients with an exposure to pergolide were asked regarding the presence or absence of chest pain, shortness of breath or lower extremity edema through a questionnaire. Echocardiograms were obtained on the same day as the questionnaire and were blinded to all staff involved in the study. The sensitivity, specificity, positive and negative predictive value of the reported symptoms towards the outcome moderate or severe valvular regurgitation were obtained. Using the area under the receiver-operating characteristic curve, we also ascertained whether a relationship existed between symptoms, pergolide dose and presence of VHD. To understand the associations between symptoms and echocardiographic covariates, a logistic regression analysis was performed adjusted for age and gender. RESULTS: The sensitivity, specificity, positive and negative predictive value of symptom presentation and total dose was sufficiently low that it did not aid in the determination whether significant valvular regurgitation was present. Multivariable analysis noted a significant association with indexed left atrial volume (p = 0.011), estimated pulmonary artery pressure (p = 0.047) and shortness of breath. CONCLUSIONS: The presence or absence of symptoms does not help guide whether valvular regurgitation is present or absent in individuals exposed to pergolide. Therefore, echocardiography is needed to confirm or refute pergolide-associated VHD.


Assuntos
Agonistas de Dopamina/efeitos adversos , Doenças das Valvas Cardíacas/induzido quimicamente , Doenças das Valvas Cardíacas/diagnóstico , Pergolida/efeitos adversos , Idoso , California , Estudos Transversais , Bases de Dados Factuais , Agonistas de Dopamina/administração & dosagem , Agonistas de Dopamina/uso terapêutico , Relação Dose-Resposta a Droga , Eletrocardiografia , Feminino , Doenças das Valvas Cardíacas/epidemiologia , Humanos , Modelos Logísticos , Masculino , Análise Multivariada , Pergolida/administração & dosagem , Pergolida/uso terapêutico , Valor Preditivo dos Testes , Estudos Prospectivos , Fatores de Tempo
2.
J Invasive Cardiol ; 22(4): 195, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20351393

RESUMO

We present the case of a 54-year-old male with a St. Jude aortic valve replacement who presented with fever and a new diastolic murmur. An echocardiogram identified a pseudoaneurysm that appeared to originate from the left sinus of Valsalva. In anticipation of open valve surgery, a 64-slice computed tomographic (CT) angiogram was performed to characterize the size and location of the pseudoaneurysm. In addition, the CT scan was able to rule out significant coronary artery disease and obviate the need to perform a potentially high-risk catheterdirected angiogram in the setting of an infected pseudoaneurysm.


Assuntos
Falso Aneurisma/cirurgia , Aneurisma Aórtico/cirurgia , Valva Aórtica/cirurgia , Endocardite Bacteriana/cirurgia , Próteses Valvulares Cardíacas , Resistência a Meticilina , Infecções Relacionadas à Prótese/cirurgia , Seio Aórtico , Infecções Estafilocócicas/cirurgia , Staphylococcus epidermidis , Falso Aneurisma/diagnóstico , Antibacterianos/administração & dosagem , Aneurisma Aórtico/diagnóstico , Prótese Vascular , Ecocardiografia Transesofagiana , Endocardite Bacteriana/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade , Cuidados Pós-Operatórios , Infecções Relacionadas à Prótese/diagnóstico , Reoperação , Infecções Estafilocócicas/diagnóstico , Tomografia Computadorizada Espiral , Vancomicina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA